GE HealthCare Net Worth
GE HealthCare Net Worth Breakdown | GEHC |
GE HealthCare Net Worth Analysis
GE HealthCare's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including GE HealthCare's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of GE HealthCare's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform GE HealthCare's net worth analysis. One common approach is to calculate GE HealthCare's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares GE HealthCare's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing GE HealthCare's net worth. This approach calculates the present value of GE HealthCare's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of GE HealthCare's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate GE HealthCare's net worth. This involves comparing GE HealthCare's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into GE HealthCare's net worth relative to its peers.
To determine if GE HealthCare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding GE HealthCare's net worth research are outlined below:
| GE HealthCare Techno generated a negative expected return over the last 90 days | |
| Over 84.0% of the company shares are owned by institutional investors | |
| On 15th of November 2024 GE HealthCare paid 0.03 per share dividend to its current shareholders | |
| Latest headline from massdevice.com: GE HealthCare unveils new mammography system |
GE HealthCare Quarterly Good Will |
|
GE HealthCare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in GE HealthCare Technologies. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to GE HealthCare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 6th of February 2024 Upcoming Quarterly Report | View | |
| 23rd of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Follow GE HealthCare's market capitalization trends
The company currently falls under 'Large-Cap' category with a current market capitalization of 37.92 B.Market Cap |
|
Project GE HealthCare's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.09 | 0.17 | |
| Return On Capital Employed | 0.10 | 0.14 | |
| Return On Assets | 0.05 | 0.08 | |
| Return On Equity | 0.22 | 0.14 |
When accessing GE HealthCare's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures GE HealthCare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of GE HealthCare's profitability and make more informed investment decisions.
Please note, the presentation of GE HealthCare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, GE HealthCare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of GE HealthCare's management manipulating its earnings.
Evaluate GE HealthCare's management efficiency
GE HealthCare Techno has return on total asset (ROA) of 0.0564 % which means that it generated a profit of $0.0564 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2185 %, meaning that it created $0.2185 on every $100 dollars invested by stockholders. GE HealthCare's management efficiency ratios could be used to measure how well GE HealthCare manages its routine affairs as well as how well it operates its assets and liabilities. At present, GE HealthCare's Return On Capital Employed is projected to slightly decrease based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.08, whereas Return On Equity is forecasted to decline to 0.14. At present, GE HealthCare's Return On Tangible Assets are projected to slightly decrease based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.57, whereas Total Assets are forecasted to decline to about 30.4 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 16.07 | 29.10 | |
| Tangible Book Value Per Share | (15.12) | (14.36) | |
| Enterprise Value Over EBITDA | 11.99 | 7.62 | |
| Price Book Value Ratio | 4.93 | 5.18 | |
| Enterprise Value Multiple | 11.99 | 7.62 | |
| Price Fair Value | 4.93 | 5.18 | |
| Enterprise Value | 30 B | 26.6 B |
Examining the leadership quality of GE HealthCare Technologies offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Enterprise Value Revenue 2.306 | Revenue 19.6 B | Quarterly Revenue Growth 0.009 | Revenue Per Share 42.916 | Return On Equity 0.2185 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific GE HealthCare insiders, such as employees or executives, is commonly permitted as long as it does not rely on GE HealthCare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases GE HealthCare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
GE HealthCare Corporate Filings
8K | 21st of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
| 8th of November 2024 Other Reports | ViewVerify | |
FWP | 7th of November 2024 A written communication used by offering participants to offer securities to the public or to solicit securities transactions. | ViewVerify |
GE HealthCare Earnings per Share Projection vs Actual
GE HealthCare Corporate Executives
Elected by the shareholders, the GE HealthCare's board of directors comprises two types of representatives: GE HealthCare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GEHC. The board's role is to monitor GE HealthCare's management team and ensure that shareholders' interests are well served. GE HealthCare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GE HealthCare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Saccaro | VP CFO | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GE HealthCare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GE HealthCare. If investors know GEHC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GE HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.242 | Dividend Share 0.12 | Earnings Share 3.65 | Revenue Per Share 42.916 | Quarterly Revenue Growth 0.009 |
The market value of GE HealthCare Techno is measured differently than its book value, which is the value of GEHC that is recorded on the company's balance sheet. Investors also form their own opinion of GE HealthCare's value that differs from its market value or its book value, called intrinsic value, which is GE HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GE HealthCare's market value can be influenced by many factors that don't directly affect GE HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GE HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if GE HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GE HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.